A detailed history of Geode Capital Management, LLC transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 382,613 shares of BDTX stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
382,613
Previous 350,446 9.18%
Holding current value
$1.83 Million
Previous $984,000 97.05%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$2.67 - $5.74 $85,885 - $184,638
32,167 Added 9.18%
382,613 $1.94 Million
Q4 2023

Feb 13, 2024

BUY
$1.77 - $3.03 $46,294 - $79,249
26,155 Added 8.07%
350,446 $984,000
Q3 2023

Nov 13, 2023

BUY
$2.87 - $4.99 $152,351 - $264,889
53,084 Added 19.57%
324,291 $930,000
Q2 2023

Aug 11, 2023

BUY
$1.43 - $6.18 $1,113 - $4,814
779 Added 0.29%
271,207 $1.37 Million
Q1 2023

May 15, 2023

BUY
$1.35 - $3.14 $6,936 - $16,133
5,138 Added 1.94%
270,428 $511,000
Q4 2022

Feb 13, 2023

BUY
$1.28 - $2.51 $951 - $1,864
743 Added 0.28%
265,290 $477,000
Q3 2022

Nov 14, 2022

BUY
$1.96 - $4.01 $34,964 - $71,534
17,839 Added 7.23%
264,547 $447,000
Q2 2022

Aug 12, 2022

SELL
$1.5 - $3.63 $277,974 - $672,697
-185,316 Reduced 42.89%
246,708 $606,000
Q1 2022

May 13, 2022

BUY
$2.66 - $5.61 $95,379 - $201,157
35,857 Added 9.05%
432,024 $1.2 Million
Q4 2021

Feb 11, 2022

BUY
$5.18 - $8.48 $239,248 - $391,665
46,187 Added 13.2%
396,167 $2.11 Million
Q3 2021

Nov 12, 2021

SELL
$8.46 - $12.42 $81,402 - $119,505
-9,622 Reduced 2.68%
349,980 $2.96 Million
Q2 2021

Aug 13, 2021

BUY
$12.19 - $28.17 $757,791 - $1.75 Million
62,165 Added 20.9%
359,602 $4.38 Million
Q1 2021

May 12, 2021

BUY
$22.23 - $34.75 $611,591 - $956,042
27,512 Added 10.19%
297,437 $7.22 Million
Q4 2020

Feb 12, 2021

BUY
$29.47 - $35.0 $654,204 - $776,965
22,199 Added 8.96%
269,925 $8.65 Million
Q3 2020

Nov 13, 2020

BUY
$26.17 - $43.07 $1.73 Million - $2.84 Million
65,962 Added 36.29%
247,726 $7.49 Million
Q2 2020

Aug 13, 2020

BUY
$22.3 - $44.8 $2.04 Million - $4.09 Million
91,367 Added 101.07%
181,764 $7.66 Million
Q1 2020

May 14, 2020

BUY
$18.18 - $39.3 $1.64 Million - $3.55 Million
90,397 New
90,397 $2.26 Million

Others Institutions Holding BDTX

About Black Diamond Therapeutics, Inc.


  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $174M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.